← All decks

General Surgery

Perspective on Pancreatic Neoplasms (A)

Built from Maingot's Abdominal Operations

What’s inside

6 sections · 101 slides

  1. 01

    Overview

    • Scope of this perspective
    • Anatomy of the pancreas that the argument rests on
    • Exocrine and endocrine pancreas
    • Why the topic has changed in one generation

    4 slides

  2. 02

    Staging cancer of the pancreatic head

    Reading the tumour-vessel relationship on CT, and deciding what to do first

    • Purpose of preoperative staging
    • Case for referral to a high-volume centre
    • Endoscopic ultrasound-guided fine-needle biopsy of the pancreas
    • Fine-needle aspiration cytology of pancreatic adenocarcinoma
    • Arteries and veins that define resectability
    • Celiac trunk and superior mesenteric artery around the pancreas
    • Imaging features of early pancreatic ductal adenocarcinoma
    • Pancreatic-region mass on contrast-enhanced abdominal CT
    • Varadhachary CT-based classification
    • Assumptions built into the Varadhachary definitions
    • Varadhachary/Katz CT staging system for adenocarcinoma of the pancreatic head and uncinate process
    • Reading the staging table
    • Katz subtypes of borderline resectable disease
    • Three forms of borderline resectable disease
    • Type B: the biologic borderline patient
    • Type C: the physiologic borderline patient
    • What the Katz classification contributed
    • AHPBA-SSO-SSAT consensus definition of resectable
    • Two definitions of resectable compared
    • Current consensus when surgery comes first
    • Open questions in borderline resectable disease
    • Regimens borrowed from metastatic disease
    • Parts of the schedule that remain undefined
    • ACOSOG Z5041 trial

    24 slides

  3. 03

    Pancreaticoduodenectomy and local recurrence

    The superior mesenteric artery dissection, and why the cancer comes back where it does

    • Pancreaticoduodenectomy in outline
    • Reconstruction after pancreaticoduodenectomy
    • Exposing the superior mesenteric artery
    • Pathophysiology of local recurrence
    • How perineural spread produces local recurrence
    • Consequence of better systemic therapy

    6 slides

  4. 04

    Cystic neoplasms of the pancreas

    Serous cystadenoma, mucinous cystic neoplasm and intraductal papillary mucinous neoplasm

    • Three cystic neoplasms that dominate practice
    • Growing importance of cystic lesions
    • Large pancreatic cyst on abdominal CT
    • Biology of serous cystadenoma
    • Venous complications of serous cystadenoma
    • Diagnosing serous cystadenoma
    • Microcystic serous cystadenoma histology
    • Role of EUS-guided aspiration in serous lesions
    • Deciding on surgery for serous cystadenoma
    • Observation policy for smaller serous lesions
    • Diagnostic criterion for mucinous cystic neoplasm
    • Mucinous cystic neoplasm with ovarian-type stroma
    • Size and malignant potential in MCN
    • Location of mucinous cystic neoplasms
    • Worked example: a 3 cm mucinous lesion in the body
    • Choice of operation for a body MCN
    • Middle segment pancreatectomy as the preferred operation
    • Sendai guidelines for intraductal papillary mucinous neoplasm
    • Intraductal papillary mucinous neoplasm histology
    • Rationale for observing low-risk IPMN
    • Debate over enucleation and ablation in small IPMN
    • Frozen-section assessment of the transection margin
    • Limits of frozen-section expertise
    • IPMN at the neck of the pancreas
    • Margin planning in extended distal pancreatectomy
    • Follow-up after resection for IPMN

    26 slides

  5. 05

    Pancreatic neuroendocrine tumours

    Biology that behaves quite unlike ductal cancer, and the operations it calls for

    • Definition and nomenclature
    • Pancreatic neuroendocrine tumour histology
    • Behaviour of sporadic insulinoma
    • Synchronous and metachronous metastases
    • Size and metastatic risk in MEN1
    • Observing small nonfunctioning pNETs in MEN1
    • Zollinger-Ellison syndrome and the origin of gastrinoma
    • Pancreatic gastrinoma
    • Duodenal carcinoid tumours
    • Well-differentiated neuroendocrine tumour of the duodenum
    • Molecular origin of duodenal and pancreatic gastrinomas
    • Causes of a raised serum gastrin level
    • Distinguishing gastrinoma from parietal cell dysfunction
    • Regional lymphadenectomy in neuroendocrine surgery
    • Biochemical diagnosis of insulinoma
    • The observed fast
    • Interpreting the glucagon response
    • Distribution of insulinoma within the pancreas
    • Local recurrence after enucleation
    • Technique of insulinoma enucleation
    • Open versus laparoscopic enucleation
    • Managing the pancreatic duct during enucleation
    • Genetic testing and syndromic associations
    • Timing surgery for MEN1 nonfunctional pNETs
    • The Thompson procedure
    • Completion total pancreatectomy in MEN1
    • Targeted systemic therapy for metastatic pNETs
    • Indolent metachronous recurrence and octreotide
    • Multidisciplinary management of low-volume metastatic disease
    • Selecting nonfunctioning pNETs for surgery
    • Liver metastases: exocrine versus neuroendocrine
    • Sequencing pancreas and liver surgery
    • Portal vein embolization and staged hepatectomy
    • Outlook for pancreatic neuroendocrine tumours

    34 slides

  6. 06

    Take-home points

    What to carry away from this perspective

    • Take-home points on staging and sequencing
    • Take-home points on cystic neoplasms
    • Take-home points on neuroendocrine tumours
    • References
    • References (continued)
    • References (continued)
    • Maingot's Abdominal Operations, 12th Edition

    7 slides